is hsct an option for refractory aml?
Published 4 years ago • 138 plays • Length 6:51Download video MP4
Download video MP3
Similar videos
-
2:25
why could imgn632 be an important treatment option for aml?
-
2:26
allo-hsct and novel drugs for refractory aml
-
5:01
treatment options for high-risk aml
-
9:07
“how i treat” a patient with aml in remission after intensive chemotherapy not proceeding to hsct
-
1:40
outcomes & treatment options for patients with aml who relapse after allohsct
-
0:38
optimal time for allo-hsct in aml
-
1:20
can the new treatments for aml reduce the need for allo-hsct?
-
2:26
outcomes with ric before second hsct in secondary aml
-
2:47
advances in the treatment of relapsed/refractory acute myeloid leukemia (aml)
-
29:35
what time is the right time for transplantation?
-
3:42
recent advances in the field of allo-hsct
-
19:22
which patients should be considered for allo-hsct?
-
1:13:17
transplant options for patients with aml 2019
-
2:34
new salvage treatment for aml/mds after allogeneic transplant: the viola trial
-
2:44
considerations when selecting patients over 70 with aml for transplantation
-
6:29
issues in allogeneic hsct: therapeutic options for post-transplant relapse
-
39:01
indications for allogeneic stem cell transplantation in aml
-
2:05
emerging treatments for acute myelogenous leukemia
-
1:28:51
antibody therapy in acute leukemia: clinical considerations in conjunction with hsct